Alexander Zverev revealed his glucose monitor affected his preparation ahead of his Wimbledon semifinal victory over Taylor Fritz, saying the device displayed an inaccurate blood sugar reading that prompted him to inject more insulin than he actually needed.
The German star, who advanced to his first Wimbledon final before ultimately finishing runner-up, explained after the tournament that the monitor showed his blood glucose was significantly higher than it really was. As such, Zverev administered insulin before his warm-up, only to later discover that his blood sugar had dropped too low. "I injected myself with way too much insulin," he said, adding that the incident left him feeling physically drained and negatively affected his performance during the warm-up session before the match.
The incident has drawn attention not only because it involved one of tennis' biggest stars competing on its biggest stage, but also because Zverev has long been open about living with Type 1 diabetes while competing at the highest level of professional tennis.
Living and Competing with Type 1 Diabetes
Zverev was diagnosed with Type 1 diabetes at just four years old, a condition that requires lifelong insulin therapy because the body is unable to produce enough insulin on its own. For years, he chose not to speak publicly about the diagnosis, fearing it could change how people viewed his athletic ability.
That changed in 2022, when he launched the Alexander Zverev Foundation, a charitable organization dedicated to helping children living with Type 1 diabetes. Since then, Zverev has become an advocate for increasing awareness of the condition, encouraging young patients and their families not to let diabetes limit their ambitions.
His recent experience at Wimbledon also underscores how dependent many people with diabetes are on modern glucose-monitoring technology. While Zverev did not identify the specific device involved or explain why it malfunctioned, continuous glucose monitors (CGMs) can occasionally provide misleading results because of factors such as sensor malfunction, calibration issues, compression of the sensor during sleep or movement, delayed readings compared with blood glucose levels, or improper placement.
A Closer Look at Type 1 Diabetes and Monitoring It Properly
According to the Cleveland Clinic, Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks the insulin-producing beta cells in the pancreas. As a result, the body can no longer produce enough insulin to regulate blood sugar levels.
Unlike Type 2 diabetes, which is more commonly associated with insulin resistance and often develops later in life, Type 1 diabetes is not caused by lifestyle choices and typically begins during childhood or adolescence, although it can occur at any age.
According to MayoClinic, common symptoms of Type 1 diabetes include:
- Excessive thirst
- Frequent urination
- Increased hunger
- Unexplained weight loss
- Fatigue
- Blurred vision
- Irritability
Doctors diagnose the condition using blood glucose tests, HbA1c testing, and, in many cases, antibody testing to confirm the autoimmune nature of the disease.
Type 1 diabetes may not have a cure right now, but it can be effectively managed through lifelong insulin therapy, careful meal planning, regular physical activity, and frequent blood glucose monitoring. Many patients also rely on continuous glucose monitors and insulin pumps to help maintain stable blood sugar levels throughout the day.
Glucose monitors have significantly improved diabetes management, but no medical device is completely immune to technical issues. Healthcare providers recommend confirming unexpected readings with a finger-stick blood glucose test when possible before making significant insulin adjustments.
Zverev's experience illustrates why that extra verification step can be so important. A single inaccurate reading has the potential to affect not only athletic performance but also a person's immediate safety if it leads to excessive insulin administration.
Accurate Readings Are Crucial For Effective Treatments
The incident that occurred during Alexander Zverev's warmup match is a reminder that managing Type 1 diabetes requires constant decision-making, even for individuals with access to the latest medical technology and world-class healthcare. Devices such as continuous glucose monitors have transformed diabetes care by reducing the burden of frequent finger-stick testing and providing real-time glucose trends, but they remain tools, not infallible safeguards.
At the same time, Zverev's openness about living with Type 1 diabetes continues to inspire many families affected by the condition. The tennis player's career demonstrates that diabetes does not have to prevent someone from reaching the highest levels of sport. It should be noted, however, that his Wimbledon experience serves as an indicator that careful monitoring, reliable technology, and sound medical judgment all play vital roles in managing a lifelong condition.
